PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1461321
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1461321
Generic Sterile Injectables Market, by Drug Type, by Therapeutic Application, by Distribution Channel and by Region
Global generic sterile injectables market is estimated to be valued at USD 46.33 Bn in 2024 and is expected to exhibit a CAGR of 10.3% during the forecast period (2024-2031).
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2023/2024: | US$ 46.33 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2023/2024 to 2030/2031 CAGR: | 10.30% | 2030/2031 Value Projection: | US$ 91.91 Bn |
The generic sterile injectable are U.S. FDA approved biologics that are used for the treatment of many diseases and disorders in the vast arena of the healthcare industry. The generic sterile injectable are very inexpensive as compared to that of their branded counterparts of these drugs and performs equally well. Thus, these Injectables are heavily in demand all the time and are used in majority of hospitals and clinics across the globe. However, due to the stringent FDA regulations for the production of these injectable, the rigorous demand satisfaction of these injectable has always been a constant challenge for the key players in the global generic sterile injectable market.
The generic sterile injectable market is expected to gain steady traction in the foreseeable future as the sterile injectable products find its application across a wide number of diseases and medical condition. Manufacturers are focused on increasing the production of generic sterile injectable to meet the rising demands without compromising on the quality of the injectable.
Market Dynamics
Market players are engaged in launching new products for generic sterile injectables, this is expected to increase the growth of the global generic sterile injectables, over the forecast period. For instance, in June 2017, Baxter International Inc. announced the U.S. FDA approval and commercial launch of ready-to-use clindamycin injection in saline in three commonly prescribed formulations (300mg/50mL, 600mg/50mL, and 900mg/50mL). Clindamycin is a widely prescribed antibiotic for serious infections which is caused by susceptible anaerobic bacteria and strains of streptococci, pneumococci and staphylococci, when penicillin is inappropriate for a patient.
Key players are focusing on inorganic activities such as partnerships, this is expected to increase the growth of the global generic sterile injectables market, over the forecast period. For instance, in 2017, Novartis' generic arm Sandoz expanded its antibiotic facility in Slovenia, with an investment of over US$ 33.54 million aimed at the development and modernization of facilities. The first production lines started in 2019, after which new lines will be gradually phased in by 2023.
The company is focused on adopting inorganic growth strategies such as acquisitions to expand its global presence and improve international commercial opportunities. For instance, in August 2016, Teva Pharmaceutical Industries Ltd. completed the acquisition of Allergan's generics business. Allergan plc.is an American, Irish-domiciled pharmaceutical company.
Key features of the study:
- This report provides an in-depth analysis of the global generic sterile injectables market, provides market size (US$ Billion), and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
- It profiles leading players in the global generic sterile injectables market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
- Key companies covered as a part of this study include Baxter International Inc., AstraZeneca plc, Merck & Co., Inc., Pfizer Inc., Fresenius Kabi, Novartis International AG, Teva Pharmaceuticals, Hikma Pharmaceuticals, Dr. Reddy's Laboratory, Mylan N.V., and Sun Pharmaceutical Industries Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
- The global generic sterile injectables market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global generic sterile injectables market
Detailed Segmentation:
- Global Generic Sterile Injectables Market, By Drug Type:
- Monoclonal Antibodies
- Cytokines
- Insulin
- Peptide Hormones
- Vaccines
- Immunoglobulins
- Blood Factors
- Antibiotics
- Others
- Global Generic Sterile Injectables Market, By Therapeutic Application:
- Cancer
- Metabolic Diseases
- Cardiovascular Diseases
- Central Nervous System Disease
- Infectious Disorders
- Musculoskeletal Disorders
- Others
- Global Generic Sterile Injectables Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Generic Sterile Injectables Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles
- Baxter International Inc.
- AstraZeneca plc
- Merck & Co., Inc.
- Pfizer Inc.
- Fresenius Kabi
- Novartis International AG
- Teva Pharmaceuticals
- Hikma Pharmaceuticals
- Reddy's Laboratory
- Mylan N.V.
- Sun Pharmaceutical Industries Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Therapeutic Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Regulatory Scenario
- PEST Analysis
- Recent Product Launch/Approval
- Epidemiology
- Mergers and Acquisitions
4. Global Generic Sterile Injectables Market - Impact of Coronavirus (Covid-19) Pandemic
- Impact on Supply Chain
- Impact on Research and Development
- Government Initiatives
5. Global Generic Sterile Injectables Market, By Drug Type, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (USD Bn)
- Cytokines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (USD Bn)
- Insulin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (USD Bn)
- Peptide Hormones
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (USD Bn)
- Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (USD Bn)
- Immunoglobulins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (USD Bn)
- Blood Factors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (USD Bn)
- Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (USD Bn)
6. Global Generic Sterile Injectables Market, By Therapeutic Application, 2019 - 2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (USD Bn)
- Metabolic Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (USD Bn)
- Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (USD Bn)
- Central Nervous System Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (USD Bn)
- Infectious Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (USD Bn)
- Musculoskeletal Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (USD Bn)
7. Global Generic Sterile Injectables Market, By Distribution Channel, 2019 - 2031 (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (USD Bn)
8. Global Generic Sterile Injectables Market, By Region, 2019 - 2031 (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Regions, 2019 - 2031
- Regional Trends
- North America
- Market Size and Forecast, By Drug Type, 2019 - 2031 (US$ Bn)
- Market Size and Forecast, By Therapeutic Application, 2019 - 2031 (US$ Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031 (US$ Bn)
- Market Size and Forecast, By Country, 2019 - 2031 (US$ Bn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Drug Type, 2019 - 2031 (US$ Bn)
- Market Size and Forecast, By Therapeutic Application, 2019 - 2031 (US$ Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031 (US$ Bn)
- Market Size and Forecast, By Country, 2019 - 2031 (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Drug Type, 2019 - 2031 (US$ Bn)
- Market Size and Forecast, By Therapeutic Application, 2019 - 2031 (US$ Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031 (US$ Bn)
- Market Size and Forecast, By Country, 2019 - 2031 (US$ Bn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Drug Type, 2019 - 2031 (US$ Bn)
- Market Size and Forecast, By Therapeutic Application, 2019 - 2031 (US$ Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031 (US$ Bn)
- Market Size and Forecast, By Country, 2019 - 2031 (US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Drug Type, 2019 - 2031 (US$ Bn)
- Market Size and Forecast, By Therapeutic Application, 2019 - 2031 (US$ Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031 (US$ Bn)
- Market Size and Forecast, By Country, 2019 - 2031 (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Drug Type, 2019 - 2031 (US$ Bn)
- Market Size and Forecast, By Therapeutic Application, 2019 - 2031 (US$ Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031 (US$ Bn)
- Market Size and Forecast, By Country, 2019 - 2031 (US$ Bn)
- South Africa
- Central Africa
- North Africa
9. Competitive Landscape
- Company Profiles
- Baxter International Inc.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- AstraZeneca plc
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Merck & Co., Inc.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Pfizer Inc.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Fresenius Kabi
- Novartis International AG
- Teva Pharmaceuticals
- Hikma Pharmaceuticals
- Reddy's Laboratory
- Mylan N.V.
- Sun Pharmaceutical Industries Ltd.
10. Analyst Recommendation
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. Section
- References
- Research Methodology
- About Us and Sales Contact
